FDA-Drug2017-12-27Class II
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Premier Pharmacy Labs Inc
Hazard
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Sold states
Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
Affected count
1610 syringes
Manufactured in
8265 Commercial Way, Weeki Wachee, FL, United States
Products
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0129-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief